China's courts increase IPR prosecutions

29 January 2007

A meeting of the Supreme People's Court of China has discussed the rise in intellectual property rights violations that have been dealt with since the country acceeded to the World Trade Organization in 2001.

The SPC revealed statistics, reported in the government-controlled People's Daily newspaper, which show that, from 2002 to 2006, 54,321 IPR cases were heard in Chinese courts of first instance, an increase of 146%. Higher courts dealt with 13,170 cases, a rise of 8.9%. The majority of these consisted of copyright, Internet domain name and trade mark disputes.

The People's Daily also reported that, last year, IPR cases rose nearly 6% to 14,219 civil cases.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight